Yasuhiro Ikeda
Affiliations: | Virology and Gene Therapy | College of Medicine - Mayo Clinic |
Area:
Virology Biology, Microbiology Biology, ImmunologyGoogle:
"Yasuhiro Ikeda"Children
Sign in to add trainee| Ryan Nini | research assistant | College of Medicine - Mayo Clinic (Cell Biology Tree) | |
| Seiga Ohmine | grad student | 2010 | College of Medicine - Mayo Clinic |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Budzik KM, Nace RA, Ikeda Y, et al. (2021) Oncolytic Foamy Virus - generation and properties of a nonpathogenic replicating retroviral vector system that targets chronically proliferating cancer cells. Journal of Virology |
| Zhu Y, Tonne JM, Liu Q, et al. (2019) Targeted Derivation of Organotypic Glucose- and GLP-1-Responsive β Cells Prior to Transplantation into Diabetic Recipients. Stem Cell Reports |
| Ohmine S, Salisbury JL, Ingle J, et al. (2018) Aurora-A overexpression is linked to development of aggressive teratomas derived from humans iPS cells. Oncology Reports |
| Morsy SG, Tonne JM, Zhu Y, et al. (2017) Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population. Bmc Research Notes. 10: 720 |
| Hickey RD, Mao SA, Glorioso J, et al. (2016) Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1. Science Translational Medicine. 8: 349ra99 |
| El Khatib MM, Ohmine S, Jacobus EJ, et al. (2016) Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration. Stem Cells Translational Medicine |
| Morsy SG, Tonne J, Zhu Y, et al. (2016) 543. In Vivo Beta-Cell-Targeted Gene Editing by AAV Vectors Molecular Therapy. 24: S217 |
| Schreiber CA, Holditch S, Generous A, et al. (2016) 297. The Influence of ELABELA AAV Gene Therapy on Cardiorenal Function in Rat Models of Salt-Induced Hypertension and Myocardial Infarction Molecular Therapy. 24: S119 |
| Bongers CA, Holditch SJ, Schreiber CA, et al. (2016) 172. B-Type Natriuretic Peptide Gene Therapy as a Novel Early Treatment for Familial Hypertrophic Cardiomyopathy Molecular Therapy. 24: S67 |
| Schreiber CA, Izumiya Y, Asokan A, et al. (2016) 8. Further Characterization of U2 snRNP Mediated Restriction of AAV Vector Transduction Molecular Therapy. 24: S4-S5 |